Clinical Trials | July 13, 2022
SRL Diagnostics launches fatty liver index
An algorithm based testing for Fatty Liver Disease
An algorithm based testing for Fatty Liver Disease
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
The AICVD tool can predict the risk of cardiovascular disease.
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Healthcare is timely and personal – and its delivery should be too
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Subscribe To Our Newsletter & Stay Updated
